About us

GM PHARMA is an international pharmaceutical company with medicines and food supplements manufactured in GMP-certified manufacturing plants in Western European countries (Germany, Greece, Spain, Switzerland, Italy, Sweden, Portugal) and in its own GMP-certified manufacturing plant in Georgia.

Learn More

HISTORY

GM PHARMA's history dates back 23 years to the late '90s, following the Soviet Union's collapse, when Georgia faced a significant shortage of pharmaceutical products. This challenging period sparked the initiative to establish a global pharmaceutical company in Georgia, adhering to international standards. Overcoming considerable obstacles, GM PHARMA introduced its first medication, Rifampicin capsules, in February 2000. Since its inception, the company has consistently focused on improving product quality through scientific approaches and industry best practices, aiming to enhance patient life quality and longevity. Celebrating its 23rd anniversary, GM PHARMA now annually treats up to 12 million patients in Georgia and internationally, a testament to its widespread recognition and trust among consumers and healthcare professionals.

VISION

One of the best and fastest growing Pharma company in the Central & Eastern Europe region - To be in the list of the world’s top 200 pharma companies and achieve $ 1 bln in export value

MISSION

GM PHARMA misson is to improve the quality of life for as many patients as possible and prolong their lives with its drug products. GM PHARMA - Servimg those who need it most!

CORE VALUES

To touch and improve more patients’ lives with more GM Pharma brands and products every day via doctors’ prescriptions and DTC ads – Serving Those Who Needs it Most!

STRATEGY

For the next 3-4 years, GM PHARMA is set to expand into new territories, such as EU countries, Southeast Asia, South and Central Americas. The company's future plans also include investment in a greenfield construction project for a new plant. This development will enable GM PHARMA to enhance its manufacturing capacity in Oral Solid Dosage (OSD) products, and introduce sterile products like liquid ampoules and vials, lyophilized vials, as well as soft gels, oral liquids, and powders. GM PHARMA is committed to aggressive growth, continuously expanding partnerships focused on cutting-edge technologies and new therapies. These collaborations are aimed at preventing and curing pathologies and addressing unmet therapeutic needs.